Linneo Health Revenue and Competitors
Estimated Revenue & Valuation
- Linneo Health's estimated annual revenue is currently $19.9M per year.
- Linneo Health's estimated revenue per employee is $201,000
Employee Data
- Linneo Health has 99 Employees.
- Linneo Health grew their employee count by 3% last year.
Linneo Health's People
Name | Title | Email/Phone |
---|
Linneo Health Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $19.9M | 99 | 3% | N/A | N/A |
What Is Linneo Health?
Linneo Health is a Europe based global leader in the research, cultivation and supply of cannabis to improve human health and wellbeing. As the world’s only vertically integrated medicinal cannabis supplier, no other company has our 90-year heritage in the manufacturing and movement of controlled substances. We are optimally positioned to address the needs of our customers through every stage of product development, regulation and handling. We are setting the benchmark for standards and customer service in medicinal cannabis. Through ongoing investment in one of the most advanced quality control laboratories in Europe, and by applying industry-leading cultivation techniques, we are the trusted partner to address the needs of customers today and, with significant expansion capabilities, the demands of tomorrow. With an unrivalled focus on quality and driven by the firm belief that people around the world deserve to be treated with cannabis medicine of the highest standard, we bring cutting edge innovation in medicinal cannabis to partners, to deliver better patient outcomes and improve lives.
keywords:N/AN/A
Total Funding
99
Number of Employees
$19.9M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $14.9M | 99 | 30% | N/A |
#2 | $17.8M | 99 | 22% | N/A |
#3 | $14.4M | 99 | 68% | N/A |
#4 | N/A | 99 | 6% | N/A |
#5 | N/A | 99 | 6% | N/A |